EBNA promoter usage in ebv-negative burkitt lymphoma cell lines converted with a neomycin-resistant EBV strain

This publication has 25 references indexed in Scilit:

• EBV-NK Cells Interactions and Lymphoproliferative Disorders
  Leukemia & Lymphoma, 1998
• Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines.
  Proceedings of the National Academy of Sciences, 1995
• Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1
  Nature, 1995
• A novel form of Epstein-Barr virus latency in normal B cells in vivo
  Cell, 1995
• Three transcriptionally distinct forms of epstein-barr virus latency in somatic cell hybrids: Cell phenotype dependence of virus promoter usage
  Virology, 1992
• Expression of Epstein–Barr Virus Transformation–Associated Genes in Tissues of Patients with EBV Lymphoproliferative Disease
  New England Journal of Medicine, 1989
• Differential activation of cytotoxic responses by Burkitt's lymphoma (BL)-cell lines: Relationship to the BL-cell surface phenotype
  Cellular Immunology, 1986
• 9-Alkyl anthracyclines. Absence of cross-resistance to adriamycin in human and murine cell cultures
  British Journal of Cancer, 1986
• Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene
  Nucleic Acids Research, 1985
• An EBV-Genome-Negative Cell Line Established from an American Burkitt Lymphoma; Receptor Characteristics. EBV Infectibility and Permanent Conversion into EBV-Positive Sublines by in vitro Infection
  Intervirology, 1975